Healthcare / Medical Care FacilitiesUpdated 2026-05-10 22:07 UTC

NSE/MEDANTA stock hub

NSE/MEDANTA has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/MEDANTAis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

322.8B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/MEDANTA

In the news

Latest news · NSE/MEDANTA

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E48.9

P25 24.9P50 32.4P75 45.7

Trailing P/E62.9

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC15.7

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/MEDANTA market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

177

Groups with data

Currency

INR

Showing 177 of 177 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	10,260
Employees Change	1,208%
Employees Change Percent	13.35
Enterprise value	INR 320.1B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical Care Facilities
Isin	INE474Q01031
Last refreshed	2026-05-10
Market cap	INR 322.8B
Price	INR 1,202
Price currency	INR
Rev Per Employee	4,076,367.45x
Sector	Healthcare
Sic	8060
Symbol	nse/MEDANTA
Website	https://www.medanta.org

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.59%
EV Earnings	62.28x
EV/EBIT	46.1x
EV/EBITDA	35.54x
EV/Sales	7.65x
Forward P/E	48.94x
P/B ratio	8.7x
P/E ratio	62.85x
P/S ratio	7.72x
PE Ratio3 Y	58.71x
PE Ratio5 Y	58.18x
PEG ratio	2.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.6%
EBITDA Margin	21.01%
Gross margin	50.93%
Gross Profit	INR 21.3B
Gross Profit Growth	15.93%
Gross Profit Growth Q	14.83%
Gross Profit Growth3 Y	19.39%
Net Income	INR 5.1B
Net Income Growth	1.27%
Net Income Growth Q	-33.51%
Net Income Growth Years	4%
Net Income Growth3 Y	28.43%
Pretax Margin	15.81%
Profit Margin	12.29%
Profit Per Employee	INR 500,850
Profitable Years	8
Roa5y	7.21
Roe5y	12.91
ROIC	15.71
Roic5y	13.55

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-0.7%
Cagr3y	33.41%
EPS Growth	1.24
EPS Growth Q	-33.46
EPS Growth Years	4
EPS Growth3 Y	26.24
Revenue Growth	17.16x
Revenue Growth Q	18.83x
Revenue Growth Quarters	14x
Revenue Growth Years	4x
Revenue Growth3 Y	18.45x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 12.2B
Debt	INR 9.4B
Debt EBITDA	INR 1.05
Debt Equity	INR 0.25
Equity	INR 37.1B
Interest Coverage	10.49
Net Cash	INR 2.8B
Net Cash By Market Cap	INR 0.85
Net Cash Growth	-6.49%
Net Debt EBITDA	INR -0.31
Net Debt Equity	INR -0.07
Tangible Book Value	INR 36.9B
Tangible Book Value Per Share	INR 137
WACC	5.18

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	INR 0.5
Dividend Years	1
Dividend Yield	0.04%
Last Dividend	INR 0.5

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-0.7%
200-day SMA	1,217.6
3Y total return	137.47%
50-day SMA	1,088.5
50-day SMA vs 200-day SMA	50under200
All Time High	1,513.9
All Time High Change	-20.6%
All Time High Date	2024-02-16
All Time Low	390.6
All Time Low Change	207.77%
All Time Low Date	2022-11-16
ATR	36.61
Beta	0.17
Beta1y	0.24
Beta2y	0.21
Ch YTD	1.32
High	1,214.9
High52	1,456.5
High52 Date	2025-08-08
High52ch	-17.47%
Low	1,182.8
Low52	956
Low52 Date	2026-03-30
Low52ch	25.73%
Ma50ch	10.42%
Price vs 200-day SMA	-1.28%
RSI	67.28
RSI Monthly	55.59
RSI Weekly	55.31
Sharpe ratio	0.01x
Sortino ratio	0.22
Total Return	0.01%
Tr YTD	1.32
Tr1m	16.32%
Tr1w	2.6%
Tr3m	5.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 6.9B
Operating Income Growth	7.27
Operating Income Growth Q	-17.54
Operating Income Growth3 Y	20.7
Operating margin	16.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	87,228,521%
Shares Insiders	44.27%
Shares Institutions	21.24%
Shares Out	268,851,882
Shares Qo Q	-0.21%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	178,037.75x
Bv Per Share	137.8
Ch1m	16.32
Ch1w	2.6
Ch1y	-0.73
Ch3m	5.19
Ch3y	137.4
Ch6m	-3.98
Change	-0.41%
Change From Open	-0.98
Close	1,206.9
Days Gap	0.58
Depreciation Amortization	1,845,062,500
Dollar Volume	273,863,680
Earnings Date	2026-05-14
EBIT	INR 6.9B
EBITDA	INR 8.8B
EPS	INR 19.1
F Score	1
Fiscal Year End	March
Founded	2,004
Graham Number	243.39357
Graham Upside	-79.75
Income Tax	INR 1.5B
Is Primary Listing	1
Last Earnings Date	2026-02-04
Last Report Date	2025-12-31
Lynch Fair Value	INR 478
Lynch Upside	-60.27
Ma150	1,171.4
Ma150ch	2.62%
Ma20	1,121.7
Ma20ch	7.16%
Next Earnings Date	2026-05-14
Open	1,213.9
Payment Date	2025-10-18
Position In Range	59.81
Price Date	2026-05-08
Price EBITDA	INR 36.73
Ptbv Ratio	8.74
Relative Volume	1.36x
Revenue	41,823,530,000x
Tax By Revenue	3.52x
Tax Rate	22.29%
Tr6m	-3.98%
Volume	227,840

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

NSE/MEDANTA dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.0%

$0.50 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+0.0%

Dividend yield + buyback yield combined

Performance

NSE/MEDANTA stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns NSE/MEDANTA?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.2%

Share of float held by funds and institutions

Insider ownership

+44.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

NSE/MEDANTA momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

67.3

Neutral momentum band

Price vs 200-day MA

-1.3%

50/200-day relationship not available

Beta (5Y)

0.17

Less volatile than the market

Sharpe ratio

0.01

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/MEDANTA

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/MEDANTA stock rating?

nse/MEDANTA is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/MEDANTA analysis?

The full report lives at /stocks/nse/MEDANTA/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/MEDANTA?

The latest report frames nse/MEDANTA around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/MEDANTA page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.